Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

FDA grants fast track status to Miravant's Purlytin

July 10, 1998

Allergan signs collaborative agreement with Santen for brimonidine

July 10, 1998

Clinical update on Advanced Corneal Systems' Vitrase

July 6, 1998

Gene linked to inherited glaucoma

July 6, 1998

Miravant and Pharmacia & Upjohn amend Purlytin agreements

June 15, 1998

Asahi Glass, Santen develop ophthalmic agents with good safety

June 12, 1998

Latanoprost compared to unoprostone in monkeys with glaucoma

June 10, 1998

CAT's monoclonal antibody progresses in ophthalmic clinical trials

June 8, 1998

Advanced Corneal System seeks Vitrase approval in Mexico

June 4, 1998

New topical corticosteroid available in U.S. for ophthalmic use

June 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...